Quoin Pharmaceuticals is a late-stage clinical specialty pharmaceutical company focused on developing and commercializing treatments for rare and orphan diseases. Its lead product, QRX003, is a topical lotion in pivotal clinical development for Netherton Syndrome, with additional programs for Peeling Skin Syndrome. The company also has pipeline candidates QRX008 for scleroderma and QRX009 (topical rapamycin formulations) for multiple rare diseases. No products have been commercialized and no revenue has been generated to date.
expected 2026-11-19
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2025-12-31 | 0001104659-26-035251 | EDGAR | 81K words |
| 2025-03-13 | 2024-12-31 | 0001410578-25-000336 | EDGAR | 75K words |
| 2024-03-14 | 2023-12-31 | 0001410578-24-000198 | EDGAR | 72K words |
| 2023-03-15 | 2022-12-31 | 0001410578-23-000267 | EDGAR | 69K words |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-14 | 2026-06-30 | 0001104659-26-097064 | EDGAR | 16K words |
| 2025-11-06 | 2025-09-30 | 0001104659-25-107785 | EDGAR | 20K words |
| 2025-08-07 | 2025-06-30 | 0001410578-25-001613 | EDGAR | 18K words |
| 2025-05-13 | 2025-03-31 | 0001410578-25-001226 | EDGAR | 16K words |
| 2024-11-08 | 2024-09-30 | 0001410578-24-001804 | EDGAR | 20K words |
| 2024-08-08 | 2024-06-30 | 0001410578-24-001216 | EDGAR | 19K words |
| 2024-05-09 | 2024-03-31 | 0001410578-24-000701 | EDGAR | 17K words |
| 2023-11-09 | 2023-09-30 | 0001410578-23-002320 | EDGAR | 17K words |
| 2023-08-03 | 2023-06-30 | 0001410578-23-001531 | EDGAR | 16K words |
| 2023-05-09 | 2023-03-31 | 0001410578-23-000940 | EDGAR | 16K words |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-22 | 0001104659-26-109639 | EDGAR | 2K words |
| 2026-09-10 | 0001104659-26-106705 | EDGAR | 1K words |
| 2026-08-28 | 0001104659-26-102917 | EDGAR | 2K words |
| 2026-08-20 | 0001104659-26-099239 | EDGAR | 1K words |
| 2026-08-14 | 0001104659-26-097094 | EDGAR | 3K words |
| 2026-03-26 | 0001104659-26-034951 | EDGAR | 3K words |
| 2026-03-11 | 0001104659-26-026410 | EDGAR | 1K words |
| 2026-01-20 | 0001104659-26-005127 | EDGAR | 1K words |
| 2025-11-17 | 0001104659-25-113237 | EDGAR | 1K words |
| 2025-11-12 | 0001104659-25-109802 | EDGAR | 1K words |
270 total filings indexed. 246 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001671502 |
| Ticker | QNRX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | L3 |
| Website | https://www.quoinpharma.com |
| Listed | 2021-10-28 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/QNRX (~200 tokens, structured JSON with cryptographic provenance)